1. Home
  2. PDS vs NTLA Comparison

PDS vs NTLA Comparison

Compare PDS & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDS
  • NTLA
  • Stock Information
  • Founded
  • PDS 1951
  • NTLA 2014
  • Country
  • PDS Canada
  • NTLA United States
  • Employees
  • PDS N/A
  • NTLA N/A
  • Industry
  • PDS
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • PDS
  • NTLA Health Care
  • Exchange
  • PDS Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • PDS 872.2M
  • NTLA 959.4M
  • IPO Year
  • PDS N/A
  • NTLA 2016
  • Fundamental
  • Price
  • PDS $58.29
  • NTLA $9.53
  • Analyst Decision
  • PDS Buy
  • NTLA Buy
  • Analyst Count
  • PDS 1
  • NTLA 18
  • Target Price
  • PDS $95.00
  • NTLA $50.53
  • AVG Volume (30 Days)
  • PDS 76.9K
  • NTLA 3.2M
  • Earning Date
  • PDS 02-12-2025
  • NTLA 02-20-2025
  • Dividend Yield
  • PDS N/A
  • NTLA N/A
  • EPS Growth
  • PDS 62.11
  • NTLA N/A
  • EPS
  • PDS 12.37
  • NTLA N/A
  • Revenue
  • PDS $1,436,787,445.00
  • NTLA $43,086,000.00
  • Revenue This Year
  • PDS $2.38
  • NTLA $50.68
  • Revenue Next Year
  • PDS $2.42
  • NTLA N/A
  • P/E Ratio
  • PDS $4.71
  • NTLA N/A
  • Revenue Growth
  • PDS N/A
  • NTLA N/A
  • 52 Week Low
  • PDS $54.49
  • NTLA $9.25
  • 52 Week High
  • PDS $79.07
  • NTLA $34.87
  • Technical
  • Relative Strength Index (RSI)
  • PDS 30.72
  • NTLA 36.07
  • Support Level
  • PDS $59.06
  • NTLA $9.93
  • Resistance Level
  • PDS $61.37
  • NTLA $10.73
  • Average True Range (ATR)
  • PDS 1.95
  • NTLA 0.66
  • MACD
  • PDS -0.99
  • NTLA 0.08
  • Stochastic Oscillator
  • PDS 8.09
  • NTLA 13.12

About PDS Precision Drilling Corporation

Precision Drilling Corpd is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: